+7 495 640-17-71
info@dna-technology.com
ENG
RUS
We glad to present a new booklet on the test Androflor®, which clearly and concisely formed answers to questions such as - why to choice this test, indications for use, particularities of biomaterial collection and the obtained results interpretation.
It's a new complex analysis to quantify the gut microbiota composition of 0-14 years old children. The technology based on real-time PCR, one of the most accurate and fastest method, which allows to detect 99,9% of microorganism species of children's gut microbiota.
DNA-Technology has participated and successfully passed an external quality assessment by QCMD (Quality Control for Molecular Diagnostics) for the HPV PRESS-25 and HPV SURE-25 panels.
QCMD programs are globally recognized and are conducted in collaboration with leading expert centers and organizations, including the World Health Organization (WHO).
The study used the HPV QUANT-21 Quantitative REAL-TIME PCR Kit, HPV SCREEN HR14(16-18-45) REAL-TIME PCR Kit and FEMOFLOR®II reagent kits, which demonstrated 100% result concordance across all samples in both programs.
On October 21, 2025, the National Center "Russia" hosted the International Export Forum "Made in Russia" - a key event for Russian export-oriented companies. DNA Technology took an active part in the forum, presenting its advanced development - the DTprime II RT PCR instrument
This solution is designed for modern laboratories and is of interest to international partners seeking reliable and high-precision equipment.
The forum, organized by the Russian Export Center, brought together business representatives and government authorities from nearly 100 countries. Its primary goal is to promote Russian goods abroad and assist in finding reliable foreign partners.
DNA-Technology is pleased to announce our participation as a Bronze Sponsor at the 48th Annual Congress of the Indian Association of Medical Microbiologists, MICROCON 2025.
From October 1 to 3, DNA-Technology took part in the major international "Diagnopolis" exhibition and the RKLM congress. The event once again confirmed its status as the premier industry platform, uniting over 200 companies.
As part of the business program, two satellite symposia were held with our company's support:
"PCR Diagnostics of Microbiota: A Step Towards Personalized Medicine".
Experts discussed method standardization, capabilities of new PCR test systems, and clinical interpretation of results.
"Rapid Microbiology vs. Traditional Methods: Compromise or Integration?".
Participants identified ways to combine innovative solutions with proven methodologies.
On October 2nd, within the framework of the Russian Diagnostic Summit—a key event for the laboratory diagnostics industry—the ceremonial presentation of the V.V. Menshikov Award took place.
The winner in the nomination "For Partnership in Laboratory Medicine" was the company DNA-Technology.